Cargando…
Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis
PURPOSE: In the WHO diagnostic classification, prefibrotic myelofibrosis (pre-MF) is included in the category of primary myelofibrosis (PMF). However, strong evidence for this position is lacking. PATIENTS AND METHODS: We investigated whether pre-MF may be aligned along a clinical and biological con...
Autores principales: | Barosi, Giovanni, Rosti, Vittorio, Bonetti, Elisa, Campanelli, Rita, Carolei, Adriana, Catarsi, Paolo, Isgrò, Antonina M., Lupo, Letizia, Massa, Margherita, Poletto, Valentina, Viarengo, Gianluca, Villani, Laura, Magrini, Umberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334973/ https://www.ncbi.nlm.nih.gov/pubmed/22536419 http://dx.doi.org/10.1371/journal.pone.0035631 |
Ejemplares similares
-
JAK2 V617F Genotype Is a Strong Determinant of Blast Transformation in Primary Myelofibrosis
por: Barosi, Giovanni, et al.
Publicado: (2013) -
Clinical Relevance of VEGFA (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and Outcomes
por: Villani, Laura, et al.
Publicado: (2021) -
VEGFA rs3025039 is associated with phenotype severity of myelofibrosis‐type megakaryocyte dysplasia
por: Barosi, Giovanni, et al.
Publicado: (2023) -
New Markers of Disease Progression in Myelofibrosis
por: Campanelli, Rita, et al.
Publicado: (2021) -
VEGFA rs3025020
Polymorphism Contributes to
CALR
-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis
por: Villani, Laura, et al.
Publicado: (2021)